Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry
Zilun Li, Meixiu Peng, Pin Chen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 424-440.e7
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 17
Differential Mechanisms of Soybean-Derived ACE2-Activating Peptides IVPQ and IAVPT in ACE2-Mediated Endothelial Protection
Minzhi Zhou, Tianyuan Song, Mingtao Huang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access | Times Cited: 1
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 45
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
Kan Huang, Zilun Li, Xi He, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 598-616.e9
Closed Access | Times Cited: 11
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients
Erik Duijvelaar, Jack Gisby, James E. Peters, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection
Xiang Gao, Shengyuan Zhang, Jizhou Gou, et al.
Journal of Infection (2022) Vol. 85, Iss. 4, pp. 418-427
Open Access | Times Cited: 34
Natural tannins as anti-SARS-CoV-2 compounds
Shao‐Chun Wang, I-Wen Chou, Mien‐Chie Hung
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4669-4676
Open Access | Times Cited: 32
The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease
Qi Wu, George Burley, Licheng Li, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 5, pp. 1147-1161
Open Access | Times Cited: 19
Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
Hamid Tanzadehpanah, Elham Lotfian, Amir Avan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115321-115321
Open Access | Times Cited: 17
Drug interactions of carbonic anhydrase inhibitors and activators
Claudiu T. Supuran
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 3, pp. 143-155
Closed Access | Times Cited: 6
Angiotensin-converting enzyme 2 and hepatic SARS-CoV-2 infection: Regulation, association, and therapeutic implications
Y. Luo, Ailong Huang, Kai‐Fu Tang
World Journal of Gastroenterology (2025) Vol. 31, Iss. 6
Closed Access
Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment?
André Schreiber, Stephan Ludwig
Antiviral Research (2025) Vol. 235, pp. 106101-106101
Open Access
Molecular docking- and reporter-based screening identify dicoumarol against ER stress-induced liver injury in mice through inhibiting IRE1α activity
Jifeng Yang, Wei Luo, Yanyu Chen, et al.
Life Sciences (2025), pp. 123526-123526
Closed Access
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
Aliakbar Hasankhani, Abolfazl Bahrami, Bahareh Tavakoli‐Far, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Identification and Screening of Potential ACE2 Activating Peptides from Soybean Protein Isolate Hydrolysate against Ang II-Induced Endothelial Dysfunction
Minzhi Zhou, Tianyuan Song, Wen Li, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 31, pp. 11957-11969
Closed Access | Times Cited: 11
Drug Repositioning of Inflammatory Bowel Disease Based on Co-Target Gene Expression Signature of Glucocorticoid Receptor and TET2
Xianglin Zhao, Chenghao Hu, Xinyu Chen, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 82-82
Open Access | Times Cited: 3
Medium‐Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway
Jianlin Zhang, Yu Cao, Ruiqing Ren, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 3
FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection
Hao Meng, Zhiying Liao, Yanting Ji, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Experimental drugs in randomized controlled trials for long-COVID: what’s in the pipeline? A systematic and critical review
Shin Jie Yong, Alice Halim, Michael Halim, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 7, pp. 655-667
Closed Access | Times Cited: 9
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic
Hongyin Chen, Jiangyun Peng, Tengyao Wang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115370-115370
Open Access | Times Cited: 13
Visible Light-Promoted Goldberg Reaction Driven by a Preponderant Facet of CuO Nanocrystals
Ze Xu, Weiwei Wang, Yuanqing Xu, et al.
ACS Catalysis (2023) Vol. 13, Iss. 21, pp. 13920-13930
Closed Access | Times Cited: 7
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD
Hanfei Chen, Qiang Chen
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4756-4767
Open Access | Times Cited: 11
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
Mohammad Sadiq Jeeyavudeen, Rahul Chaudhari, Joseph M. Pappachan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 487-502
Open Access | Times Cited: 6
Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M. Lykoudis
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1480-1487
Open Access | Times Cited: 1
Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects
Yu Zhang, Shihan Chen, Yan Tian, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top